Patients with myasthenia gravis who have both anti-AChR and anti-NRIP autoantibodies show worse outcomes than those without the anti-NRIP autoantibody [28], but the NRIP levels in MG patients remain unknown. Here, DCAF6 is linked to myasthenia gravis.